First- and Second-Generation EGFR-TKIs Are All Replaced to Osimertinib in Chemo-Naive EGFR Mutation-Positive Non-Small Cell Lung Cancer?

por Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado 2019

Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer

por Hayashi, Hidetoshi, Kurata, Takayasu, Nakagawa, Kazuhiko
Publicado 2011

Survival Outcome Assessed According to Tumor Response and Shrinkage Pattern in Patients with EGFR Mutation–Positive Non–Small-Cell Lung Cancer Treated with Gefitinib or Erlotinib...

por Takeda, Masayuki, Okamoto, Isamu, Nakagawa, Kazuhiko
Publicado 2014

Clinical development of nintedanib for advanced non-small-cell lung cancer

por Takeda, Masayuki, Okamoto, Isamu, Nakagawa, Kazuhiko
Publicado 2015

Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?

por Haratani, Koji, Hayashi, Hidetoshi, Nakagawa, Kazuhiko
Publicado 2020

Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?

por Kanemura, Hiroaki, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado 2020

Selection Pressure and Altered Hepatocellular Islands after a Single Injection of Aflatoxin B1

por Moore, Malcolm A., Nakagawa, Kazuhiko, Ishikawa, Takatoshi
Publicado 1988

Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidence

por Togashi, Yosuke, Hayashi, Hidetoshi, Nakagawa, Kazuhiko, Nishio, Kazuto
Publicado 2014

A case of severe cerebral embolism after chemotherapy for HER2-positive gastric cancer

por Takahama, Takayuki, Takeda, Masayuki, Nishina, Shinichi, Nakagawa, Kazuhiko
Publicado 2015

Successful long-term treatment of non–small cell lung cancer positive for RET rearrangement with pemetrexed

por Takeda, Masayuki, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko
Publicado 2019

Interstitial lung disease associated with capmatinib therapy in a patient with non‐small cell lung cancer harboring a skipping mutation of MET exon 14

por Kanemura, Hiroaki, Takeda, Masayuki, Shimizu, Shigeki, Nakagawa, Kazuhiko
Publicado 2020

Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevaciz...

por Takeda, Masayuki, Okamoto, Isamu, Yamanaka, Takeharu, Nakagawa, Kazuhiko, Nakanishi, Yoichi
Publicado 2012

Multiple regulatory mechanisms of hepatocyte growth factor expression in malignant cells with a short poly(dA) sequence in the HGF gene promoter

por SAKAI, KAZUKO, TAKEDA, MASAYUKI, OKAMOTO, ISAMU, NAKAGAWA, KAZUHIKO, NISHIO, KAZUTO
Publicado 2015

Gastroparesis as a significant gastrointestinal adverse event during intensive chemotherapy for solid caner: a case report

por Nakayama, Tomohiro, Haratani, Koji, Kurosaki, Takashi, Tanaka, Kaoru, Nakagawa, Kazuhiko
Publicado 2022

Efficacy of Crizotinib After Entrectinib Resistance Due to MET Polysomy in ROS1-Rearranged NSCLC: A Case Report

por Takakura, Toshiaki, Kanemura, Hiroaki, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko, Hayashi, Hidetoshi
Publicado 2023

Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of re...

por Aoyama, Yumiko, Nishimura, Tetsuya, Sawamoto, Taiji, Satoh, Taroh, Katashima, Masataka, Nakagawa, Kazuhiko
Publicado 2012

Targeting MET Amplification as a New Oncogenic Driver

por Kawakami, Hisato, Okamoto, Isamu, Okamoto, Wataru, Tanizaki, Junko, Nakagawa, Kazuhiko, Nishio, Kazuto
Publicado 2014

Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumab

por Kato, Ryoji, Hayashi, Hidetoshi, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado 2017

Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR

por Sakai, Hitomi, Hayashi, Hidetoshi, Iwasa, Tsutomu, Hasegawa, Yoshikazu, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado 2017

Treatment of EGFR mutation–positive non–small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case report

por Nonagase, Yoshikane, Takeda, Masayuki, Tanaka, Kaoru, Hayashi, Hidetoshi, Iwasa, Tsutomu, Nakagawa, Kazuhiko
Publicado 2018